{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:27:42Z","timestamp":1785940062744,"version":"3.56.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The study was aimed to compare the efficacy and safety of different sedation protocols of dexmedetomidine\u2013remifentanil and propofol\u2013remifentanil for percutaneous closure of atrial septal defects (ASD) under transthoracic echocardiography (TTE) guidance.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material and methods<\/jats:title>\n                <jats:p>From March 2020 to January 2021, of 114 patients screened, 59 ASD patients scheduled for percutaneous closure under TTE guidance were randomly allocated into the dexmedetomidine\u2013remifentanil (D\u2013R) group (n\u2009=\u200929) and the propofol\u2013remifentanil (P\u2013R) group (n\u2009=\u200930). The incidence of hemodynamic and respiratory adverse events, arterial blood gas analysis, induction and recovery time, pain score, infusion rate of remifentanil, satisfaction of the surgeon and patient, additional sedatives were collected for analysis and comparison.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The induction time was longer in the D\u2013R group than that in the P\u2013R group (17.66\u2009\u00b1\u20092.65\u00a0min vs 11.43\u2009\u00b1\u20091.48\u00a0min; difference, 6.22\u00a0min; 95% CI 5.10 to 7.35; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). No differences were observed in the 2 groups in terms of the additional sedatives, infusion rate of remifentanil, pain score, recovery time (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). There was no difference between the two groups regarding the incidence of cardiovascular adverse events (6 [20.7%] vs 4 [13.3%]; difference, 7.4%; 95% CI \u2212\u00a011.7 to 26.5%; <jats:italic>P<\/jats:italic>\u2009=\u20090.506). Respiratory adverse events occurred in 1 patient (3.4%) in the D\u2013R group, and 8 patients (26.7%) in the P\u2013R group (difference, 23.3%; 95% CI 6.2 to 40.5%; <jats:italic>P<\/jats:italic>\u2009=\u20090.026). The incidence of hypercapnia was significantly lower in the D\u2013R group (4 [13.8%]) than in the P\u2013R group (13 [43.3%]; difference, 29.5%; 95% CI 7.8 to 51.2%; <jats:italic>P<\/jats:italic>\u2009=\u20090.012).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Except for more rapid the induction time and higher the surgeon satisfaction score in the propofol\u2013remifentanil protocol, the efficacy was similar between two sedation protocols. The hemodynamic stability was comparable, the dexmedetomidine\u2013remifentanil protocol had superior airway security due to fewer hypercapnia and respiratory adverse events.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13019-022-01834-6","type":"journal-article","created":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T12:03:12Z","timestamp":1651579392000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of the efficacy and safety of sedation protocols with the use of dexmedetomidine\u2013remifentanil and propofol\u2013remifentanil during percutaneous closure of atrial septal defects: a randomized clinical trial"],"prefix":"10.1186","volume":"17","author":[{"given":"Xiao-Lan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Han","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-7555","authenticated-orcid":false,"given":"Gui-Can","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,3]]},"reference":[{"issue":"1","key":"1834_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jcin.2015.09.028","volume":"9","author":"YK Ooi","year":"2016","unstructured":"Ooi YK, Kelleman M, Ehrlich A, et al. Transcatheter versus surgical closure of atrial septal defects in children: a value comparison. JACC Cardiovasc Interv. 2016;9(1):79\u201386.","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"1834_CR2","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/echo.13106","volume":"33","author":"C Ding","year":"2016","unstructured":"Ding C, Chang JK, Lin CC, et al. Efficacy and safety of transthoracic echocardiography alone in transcatheter closure of secundum-type atrial septal defects in adults. Echocardiography. 2016;33(4):579\u201385.","journal-title":"Echocardiography"},{"issue":"44","key":"1834_CR3","doi-asserted-by":"publisher","first-page":"e5256","DOI":"10.1097\/MD.0000000000005256","volume":"95","author":"H Cao","year":"2016","unstructured":"Cao H, Chen Q, Zhang GC, et al. Percutaneous device closure of atrial septal defect with totally transthoracic echocardiography guide, without x-ray machine. Medicine (Baltimore). 2016;95(44):e5256.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1834_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jclinane.2004.06.019","volume":"17","author":"A Akin","year":"2005","unstructured":"Akin A, Guler G, Esmaoglu A, et al. A comparison of fentanyl-propofol with a ketamine-propofol combination for sedation during endometrial biopsy. J Clin Anesth. 2005;17(3):187\u201390.","journal-title":"J Clin Anesth"},{"issue":"6","key":"1834_CR5","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1053\/j.jvca.2013.03.022","volume":"27","author":"JA Curtis","year":"2013","unstructured":"Curtis JA, Hollinger MK, Jain HB. Propofol-based versus dexmedetomidine-based sedation in cardiac surgery patients. J Cardiothorac Vasc Anesth. 2013;27(6):1289\u201394.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"1834_CR6","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/cc712","volume":"4","author":"RM Venn","year":"2000","unstructured":"Venn RM, Hell J, Grounds RM. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care. 2000;4(5):302\u20138.","journal-title":"Crit Care"},{"issue":"1","key":"1834_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1213\/ane.0b013e3181ae0856","volume":"110","author":"KA Candiotti","year":"2010","unstructured":"Candiotti KA, Bergese SD, Bokesch PM, et al. MAC Study Group. Monitored anesthesia care with dexmedetomidine: a prospective, randomized, double-blind, multicenter trial. Anesth Analg. 2010;110(1):47\u201356.","journal-title":"Anesth Analg"},{"issue":"2","key":"1834_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2165\/00003495-200059020-00012","volume":"59","author":"N Bhana","year":"2000","unstructured":"Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59(2):263\u201370.","journal-title":"Drugs"},{"key":"1834_CR9","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jclinane.2016.07.035","volume":"35","author":"S Watt","year":"2016","unstructured":"Watt S, Sabouri S, Hegazy R, et al. Does dexmedetomidine cause less airway collapse than propofol when used for deep sedation? J Clin Anesth. 2016;35:259\u201367.","journal-title":"J Clin Anesth"},{"issue":"4","key":"1834_CR10","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.clinthera.2010.04.010","volume":"32","author":"S Koruk","year":"2010","unstructured":"Koruk S, Mizrak A, Kaya UB, et al. Propofol\/dexmedetomidine and propofol\/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: a prospective randomized study. Clin Ther. 2010;32(4):701\u20139.","journal-title":"Clin Ther"},{"issue":"6","key":"1834_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s002460010280","volume":"22","author":"D Gozal","year":"2001","unstructured":"Gozal D, Rein AJ, Nir A, et al. Propofol does not modify the hemodynamic status of children with intracardiac shunts undergoing cardiac catheterization. Pediatr Cardiol. 2001;22(6):488\u201390.","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"1834_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1213\/00000539-200208000-00042","volume":"95","author":"SR Arain","year":"2002","unstructured":"Arain SR, Ebert TJ. The efficacy, side effects, and recovery characteristics of dexmedetomidine versus propofol when used for intraoperative sedation. Anesth Analg. 2002;95(2):461\u20136.","journal-title":"Anesth Analg"},{"issue":"1","key":"1834_CR13","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1213\/ANE.0000000000003633","volume":"128","author":"TI St-PP","year":"2019","unstructured":"St-PP TI, Verdonck O, et al. Dexmedetomidine versus remifentanil for monitored anesthesia care during endobronchial ultrasound-guided transbronchial needle aspiration: a randomized controlled trial. Anesth Analg. 2019;128(1):98\u2013106.","journal-title":"Anesth Analg"},{"issue":"4","key":"1834_CR14","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00004714-199008000-00003","volume":"10","author":"DA Chernik","year":"1990","unstructured":"Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer\u2019s Assessment of Alertness\/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10(4):244\u201351.","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"1834_CR15","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.3748\/wjg.v21.i12.3671","volume":"21","author":"N Kim","year":"2015","unstructured":"Kim N, Yoo YC, Lee SK, et al. Comparison of the efficacy and safety of sedation between dexmedetomidine\u2013remifentanil and propofol\u2013remifentanil during endoscopic submucosal dissection. World J Gastroenterol. 2015;21(12):3671\u20138.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1834_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1213\/00000539-197011000-00020","volume":"49","author":"JA Aldrete","year":"1970","unstructured":"Aldrete JA, Kroulik D. A postanesthetic recovery score. Anesth Analg. 1970;49(6):924\u201334.","journal-title":"Anesth Analg"},{"issue":"43","key":"1834_CR17","doi-asserted-by":"publisher","first-page":"e22712","DOI":"10.1097\/MD.0000000000022712","volume":"99","author":"S Park","year":"2020","unstructured":"Park S, Choi SL, Nahm FS, et al. Dexmedetomidine\u2013remifentanil vs propofol\u2013remifentanil for monitored anesthesia care during hysteroscopy: Randomized, single-blind, controlled trial. Medicine (Baltimore). 2020;99(43):e22712.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"1834_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/bja\/aew024","volume":"116","author":"N Goettel","year":"2016","unstructured":"Goettel N, Bharadwaj S, Venkatraghavan L, et al. Dexmedetomidine vs propofol\u2013remifentanil conscious sedation for awake craniotomy: a prospective randomized controlled trial. Br J Anaesth. 2016;116(6):811\u201321.","journal-title":"Br J Anaesth"},{"issue":"3","key":"1834_CR19","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1213\/01.ane.0000196721.49780.85","volume":"102","author":"AP Skucas","year":"2006","unstructured":"Skucas AP, Artru AA. Anesthetic complications of awake craniotomies for epilepsy surgery. Anesth Analg. 2006;102(3):882\u20137.","journal-title":"Anesth Analg"},{"issue":"43","key":"1834_CR20","doi-asserted-by":"publisher","first-page":"e1727","DOI":"10.1097\/MD.0000000000001727","volume":"94","author":"DJ Ge","year":"2015","unstructured":"Ge DJ, Qi B, Tang G, et al. Intraoperative dexmedetomidine promotes postoperative analgesia and recovery in patients after abdominal colectomy: A CONSORT-prospective, randomized. Control Clin Trial Med (Baltimore). 2015;94(43):e1727.","journal-title":"Control Clin Trial Med (Baltimore)"},{"issue":"6","key":"1834_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s12630-018-1092-4","volume":"65","author":"NP Mayr","year":"2018","unstructured":"Mayr NP, Wiesner G, van der Starre P, et al. Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support. Can J Anaesth. 2018;65(6):647\u201357.","journal-title":"Can J Anaesth"},{"issue":"2","key":"1834_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/ALN.0000000000002809","volume":"131","author":"LU Edokpolo","year":"2019","unstructured":"Edokpolo LU, Mastriano DJ, Serafin J, et al. Discharge readiness after propofol with or without dexmedetomidine for colonoscopy: a randomized controlled trial. Anesthesiology. 2019;131(2):279\u201386.","journal-title":"Anesthesiology"},{"issue":"2","key":"1834_CR23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/0300060516688408","volume":"45","author":"HM Wang","year":"2017","unstructured":"Wang HM, Shi XY, Qin XR, et al. Comparison of dexmedetomidine and propofol for conscious sedation in inguinal hernia repair: a prospective, randomized, controlled trial. J Int Med Res. 2017;45(2):533\u20139.","journal-title":"J Int Med Res"},{"issue":"1","key":"1834_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/ALN.0000000000001432","volume":"126","author":"V Salmasi","year":"2017","unstructured":"Salmasi V, Maheshwari K, Yang DS, et al. Relationship between intraoperative hypotension, defined by either reduction from baseline or absolute thresholds, and acute kidney and myocardial injury after noncardiac surgery: a retrospective cohort analysis. Anesthesiology. 2017;126(1):47\u201365.","journal-title":"Anesthesiology"},{"issue":"8","key":"1834_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s00246-011-0092-8","volume":"32","author":"JD Tobias","year":"2011","unstructured":"Tobias JD, Gupta P, Naguib A, et al. Dexmedetomidine: applications for the pediatric patient with congenital heart disease. Pediatr Cardiol. 2011;32(8):1075\u201387.","journal-title":"Pediatr Cardiol"},{"issue":"1","key":"1834_CR26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1124\/dmd.115.067405","volume":"44","author":"ZF Wu","year":"2016","unstructured":"Wu ZF, Wang S, Peng XM, et al. Altered cisatracurium pharmacokinetics and pharmacodynamics in patients with congenital heart defects. Drug Metab Dispos. 2016;44(1):75\u201382.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"1834_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4103\/0971-9784.185531","volume":"19","author":"S Hasija","year":"2016","unstructured":"Hasija S, Chauhan S, Jain P, et al. Comparison of speed of inhalational induction in children with and without congenital heart disease. Ann Card Anaesth. 2016;19(3):468\u201374.","journal-title":"Ann Card Anaesth"},{"issue":"2","key":"1834_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.5603\/KP.a2017.0214","volume":"76","author":"P Lipiec","year":"2018","unstructured":"Lipiec P, Mi\u015bkowiec D, Peruga JZ, et al. Conscious sedation for transcatheter implantation of atrial septal occluders with two- and three-dimensional transoesophageal echocardiography guidance\u2014a feasibility and safety study. Kardiol Pol. 2018;76(2):406\u201312.","journal-title":"Kardiol Pol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01834-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-022-01834-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-022-01834-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T12:11:58Z","timestamp":1651579918000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-022-01834-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1834"],"URL":"https:\/\/doi.org\/10.1186\/s13019-022-01834-6","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,3]]},"assertion":[{"value":"20 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Fujian Medical University, China (No. 2020KY018) and was registered at  (No. ChiCTR2000030969), 20 March 2020.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for publication was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have nothing to declare with regards to this project.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}